Salarius Pharmaceuticals forms research partnership with Fox Chase Cancer Center September 24, 2021 Auto Bot Clinical Development 0 The cancer-centric pharma firm will work with the Houston-based cancer center to pinpoint new indications and biomarkers for its drug candidate, seclidemstat.